• Search
  • Basket
    You have no items in your basket
 

Journals and Articles

New Frontiers in oncology: an evolving innovation ecosystem

A new study from the European Patent Office (EPO) explores how innovation ecosystems are shaping the future of oncology, with knowledge transfer playing a crucial role in bridging the gap between research and market-ready solutions. New Frontiers in Oncology: An Evolving Innovation Ecosystem provides a comprehensive analysis of patent trends in cancer-related technologies, revealing both the strengths and challenges facing Europe in this critical field.

 

Impact

BioMedical SIG #4

Learn about essential IP strategies for healthcare spin-outs, focusing on how tailored approaches for biotech, pharma, and digital health innovations can ensure long-term success. Join experts Sara Holland, Dave Holt, and Elisabeth Downey as they guide you through the key elements of a comprehensive IP strategy, including licences and agreements.

 

Impact

BioMedical SIG #1

First webinar of the series, From research and innovation to development: how to plan and execute translational projects in life sciences, From bench to bedside focuses on the process of creating new medicines. Matthias Versele, Executive Director Drug Discovery from Cistim, Belgium, presents CD3-Cistim’s strategy for the evaluation and execution of drug development projects.

 

Impact

Digital Innovations SIG: World Lunch #6

With Laura Spinardi, Head of Technology Transfer Office, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, we discussed the challenges of managing data in digital clinical research: not just the privacy/personal data issues, but also data management and data sharing within collaborative research projects, using data for machine learning and training, and the ease or difficulty of transferring data in licensing and spin out opportunities.

 

Impact

Digital Innovations SIG: World Lunch #5

Michiel Hulsbergen is CEO and founder of DialogueTrainer. In this edition of the Digital Innovation SIG World Lunch, Michiel shared the challenges he has faced setting up and running the company. As a spin-out from the Utrecht University, how did he navigate the issues of IP, funding and commercial development?

 

Toolbox

Doing Business in the United States

Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.

 

Impact

Tea with ASTP: Negotiating Licensing Terms

In this webinar recording, Anja Zimmerman, discusses how knowledge and technology transfer can happen in numerous ways, from publication of research results to collaborations between scientist, between research organisations, between academia and industry or by creating companies.